{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:00:00Z","timestamp":1777946400236,"version":"3.51.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/iae.0b013e3181e46ad8","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T10:06:05Z","timestamp":1285927565000},"page":"442-446","source":"Crossref","is-referenced-by-count":37,"title":["The Effect of Methotrexate on Corneal Neovascularization in Rabbits"],"prefix":"10.1097","volume":"30","author":[{"given":"Yong-Soo","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Kun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210204","first-page":"142","article-title":"Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids.","volume":"1","author":"Holz","year":"1992","journal-title":"Ger J Ophthalmol"},{"key":"R2-14-20210204","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","article-title":"Low-dose methotrexate therapy for ocular inflammatory disease.","volume":"99","author":"Shah","year":"1992","journal-title":"Ophthalmology"},{"key":"R3-14-20210204","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2007-1008466","article-title":"Gefassschaden durch intraarterielle Gabe von Methotrexat?","volume":"62","author":"Pau","year":"1983","journal-title":"Laryngol Rhinol Otol (Stuttg)"},{"key":"R4-14-20210204","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1254\/jjp.48.499","article-title":"Effect of methotrexate on local cerebral blood flow in conscious rats.","volume":"48","author":"Mizusawa","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"R5-14-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-14-20210204","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/1529-0131(199803)41:3<435::AID-ART9>3.0.CO;2-9","article-title":"Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa.","volume":"41","author":"Coll-Vinent","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R7-14-20210204","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/anr.1780320903","article-title":"Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.","volume":"32","author":"Hirata","year":"1989","journal-title":"Arthritis Rheum"},{"key":"R8-14-20210204","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-14-20210204","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02256101","article-title":"Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.","volume":"11","author":"Huang","year":"2004","journal-title":"J Biomed Sci"},{"key":"R10-14-20210204","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1167\/iovs.07-1641","article-title":"Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment.","volume":"49","author":"Chong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-14-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review.","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"R12-14-20210204","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-14-20210204","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1158\/0008-5472.CAN-04-2345","article-title":"Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis.","volume":"65","author":"Bjorndahl","year":"2005","journal-title":"Cancer Res"},{"key":"R14-14-20210204","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1096\/fj.03-1179fje","article-title":"VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.","volume":"18","author":"Hong","year":"2004","journal-title":"FASEB J"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-201104000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:24:52Z","timestamp":1618277092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201104000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181e46ad8","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}